Financial reports
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-KT
Annual report (with FYE transition)
1 May 23
10-Q
2023 Q1
Quarterly report
14 Nov 22
10-K
2022 FY
Annual report
28 Sep 22
10-Q
2022 Q3
Quarterly report
12 May 22
10-Q
2022 Q2
Quarterly report
9 Feb 22
10-Q
2022 Q1
Quarterly report
10 Nov 21
Current reports
8-K
Completion of Acquisition or Disposition of Assets
16 Apr 24
8-K
Changes in Registrant's Certifying Accountant
8 Apr 24
8-K
Entry into a Material Definitive Agreement
3 Apr 24
8-K
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results
28 Mar 24
8-K
Other Events
25 Mar 24
8-K
Other Events
19 Mar 24
8-K
Other Events
7 Mar 24
8-K
Perspective Therapeutics Announces $87.4 Million Private Placement
6 Mar 24
8-K
Other Events
5 Feb 24
8-K
Perspective Therapeutics Announces Proposed Public Offering
22 Jan 24
Registration and prospectus
424B3
Prospectus supplement
9 Apr 24
S-8
Registration of securities for employees
1 Apr 24
S-3
Shelf registration
29 Mar 24
D
$87.41 mm in equity, sold $87.41 mm, 9 investors
18 Mar 24
D
$20.85 mm in equity, sold $20.85 mm, 1 investor
22 Jan 24
424B5
Prospectus supplement for primary offering
18 Jan 24
424B5
Prospectus supplement for primary offering
17 Jan 24
S-3/A
Shelf registration (amended)
6 Dec 23
S-3
Shelf registration
17 Nov 23
424B5
Prospectus supplement for primary offering
15 Nov 23
Proxies
DEFA14A
Additional proxy soliciting materials
18 Apr 24
DEF 14A
Definitive proxy
18 Apr 24
PRE 14A
Preliminary proxy
8 Apr 24
DEFA14A
Additional proxy soliciting materials
22 Aug 23
DEF 14A
Definitive proxy
22 Aug 23
DEFA14A
Additional proxy soliciting materials
12 Jan 23
DEFA14A
Additional proxy soliciting materials
14 Dec 22
DEFA14A
Additional proxy soliciting materials
6 Dec 22
DEFM14A
Proxy related to merger
7 Nov 22
PREM14A
Preliminary proxy related to merger
25 Oct 22
Other
EFFECT
Notice of effectiveness
10 Apr 24
EFFECT
Notice of effectiveness
15 Dec 23
CORRESP
Correspondence with SEC
13 Dec 23
CORRESP
Correspondence with SEC
6 Dec 23
UPLOAD
Letter from SEC
30 Nov 23
SD
Conflict minerals disclosure
14 Jun 23
SD
Conflict minerals disclosure
26 May 22
SD
Conflict minerals disclosure
27 May 21
SD
Conflict minerals disclosure
26 May 20
EFFECT
Notice of effectiveness
5 Feb 20
Ownership
4
Mark John Austin
24 Apr 24
SC 13G
COMMODORE CAPITAL LP
19 Apr 24
4
Change in insider ownership
8 Mar 24
SC 13D/A
Lantheus Holdings, Inc.
8 Mar 24
4
Robert F Williamson III
1 Feb 24
3
Initial statement of insider ownership
1 Feb 24
SC 13D
Lantheus Holdings, Inc.
1 Feb 24
4
Robert F Williamson III
30 Jan 24
4
Markus Puhlmann
26 Jan 24
4
Robert F Williamson III
26 Jan 24